72 related articles for article (PubMed ID: 12680211)
41. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
43. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
44. Identification of Wnt pathway, uPA, PAI-1, MT1-MMP, S100A4 and CXCR4 associated with enhanced metastasis of human large cell lung cancer by DNA microarray.
Qiu X; Guo S; Wu H; Chen J; Zhou Q
Minerva Med; 2012 Jun; 103(3):151-64. PubMed ID: 22653095
[TBL] [Abstract][Full Text] [Related]
45. Focusing on transcription factor families in atherogenesis: the function of LKLF and TR3.
Arkenbout EK; Dekker RJ; de Vries CJ; Horrevoets AJ; Pannekoek H
Thromb Haemost; 2003 Mar; 89(3):522-9. PubMed ID: 12624637
[TBL] [Abstract][Full Text] [Related]
46. [Methylation profile difference in human high-metastatic large cell lung cancer cell line L9981 and low-metastatic large cell lung cancer line NL9980].
Lv H; Yan H; Wang M; Li Y; Wan H; Liu H; Wu H; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):763-8. PubMed ID: 20704814
[TBL] [Abstract][Full Text] [Related]
47. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
Kwei KA; Kim YH; Girard L; Kao J; Pacyna-Gengelbach M; Salari K; Lee J; Choi YL; Sato M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
Oncogene; 2008 Jun; 27(25):3635-40. PubMed ID: 18212743
[TBL] [Abstract][Full Text] [Related]
48. Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation.
Sharifzadeh S; Owji SM; Pezeshki AM; Malek-Hoseini Z; Kumar PV; Ghayumi SM; Ghaderi A
Pathol Oncol Res; 2004; 10(4):225-30. PubMed ID: 15619644
[TBL] [Abstract][Full Text] [Related]
49. Unraveling the large cell lung carcinoma-specific miRNA profile and the downstream regulation network.
Gong Y; Li X; Deng L; Jin L; Jin Y; Jin Y
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1082-1085. PubMed ID: 31555828
[No Abstract] [Full Text] [Related]
50. Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases.
Morgat C; Chastel A; Molinie V; Schollhammer R; Macgrogan G; Vélasco V; Malavaud B; Fernandez P; Hindié E
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959962
[TBL] [Abstract][Full Text] [Related]
51. Autoimmune Encephalitis.
Leypoldt F; Wandinger KP; Bien CG; Dalmau J
Eur Neurol Rev; 2013; 8(1):31-37. PubMed ID: 27330568
[TBL] [Abstract][Full Text] [Related]
52. Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.
Loginov VI; Dmitriev AA; Senchenko VN; Pronina IV; Khodyrev DS; Kudryavtseva AV; Krasnov GS; Gerashchenko GV; Chashchina LI; Kazubskaya TP; Kondratieva TT; Lerman MI; Angeloni D; Braga EA; Kashuba VI
PLoS One; 2015; 10(5):e0123369. PubMed ID: 25961819
[TBL] [Abstract][Full Text] [Related]
53. BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis.
Wan Q; Dingerdissen H; Fan Y; Gulzar N; Pan Y; Wu TJ; Yan C; Zhang H; Mazumder R
Database (Oxford); 2015; 2015():. PubMed ID: 25819073
[TBL] [Abstract][Full Text] [Related]
54. Emerging roles of Semaphorins in the regulation of epithelial and endothelial junctions.
Treps L; Le Guelte A; Gavard J
Tissue Barriers; 2013 Jan; 1(1):e23272. PubMed ID: 24665374
[TBL] [Abstract][Full Text] [Related]
55. Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.
Wu Z; Martinez-Fong D; Trédaniel J; Forgez P
Front Endocrinol (Lausanne); 2012; 3():184. PubMed ID: 23335914
[TBL] [Abstract][Full Text] [Related]
56. Semaphorins and their receptors in lung cancer.
Potiron VA; Roche J; Drabkin HA
Cancer Lett; 2009 Jan; 273(1):1-14. PubMed ID: 18625544
[TBL] [Abstract][Full Text] [Related]
57. The semaphorins.
Yazdani U; Terman JR
Genome Biol; 2006; 7(3):211. PubMed ID: 16584533
[TBL] [Abstract][Full Text] [Related]
58. Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line.
de Lange R; Dimoudis N; Weidle UH
Anticancer Res; 2003; 23(1A):187-94. PubMed ID: 12680211
[TBL] [Abstract][Full Text] [Related]
59. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.
Euer N; Schwirzke M; Evtimova V; Burtscher H; Jarsch M; Tarin D; Weidle UH
Anticancer Res; 2002; 22(2A):733-40. PubMed ID: 12014644
[TBL] [Abstract][Full Text] [Related]
60. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.
Halmos B; Bassères DS; Monti S; D'Aló F; Dayaram T; Ferenczi K; Wouters BJ; Huettner CS; Golub TR; Tenen DG
Cancer Res; 2004 Jun; 64(12):4137-47. PubMed ID: 15205324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
